JAZZ PHARMACEUTICALS FRANCE

🇫🇷France
Ownership
-
Established
2003-01-01
Employees
-
Market Cap
-
Website
https://www.jazzpharma.com/careers/open-positions/

CPX-351 Real-World Effectiveness and Safety Study

Completed
Conditions
Interventions
First Posted Date
2021-12-23
Last Posted Date
2022-07-12
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
147
Registration Number
NCT05169307
Locations
🇬🇧

University Hospitals Derby and Burton, Derby, United Kingdom

🇬🇧

Royal Marsden, London, United Kingdom

🇬🇧

Bristol Royal Infirmary, Bristol, United Kingdom

and more 12 locations

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

First Posted Date
2021-12-09
Last Posted Date
2024-11-18
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
918
Registration Number
NCT05152147
Locations
🇦🇷

Hospital de Gastroenterología Dr Bonorino Udaondo, Buenos Aires, Argentina

🇦🇷

Fundación Centro de Medicina Nuclear y Molecular ER, Córdoba, Argentina

🇦🇷

Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

and more 310 locations

Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors (EMERGE-201)

First Posted Date
2021-11-19
Last Posted Date
2024-02-26
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
47
Registration Number
NCT05126433
Locations
🇺🇸

Stanford Cancer Center, Stanford, California, United States

🇺🇸

Levine Cancer Institute, Charlotte, North Carolina, United States

🇺🇸

Bon Secours Hematology and Oncology, Greenville, South Carolina, United States

and more 14 locations

A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-11-17
Last Posted Date
2024-07-30
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
420
Registration Number
NCT05122650
Locations
🇺🇸

Keck School of Medicine USC - Healthcare Consultation Center 2 (HCCII), Los Angeles, California, United States

🇺🇸

Innovative Research Of West Florida, Inc., Clearwater, Florida, United States

🇺🇸

Houston Methodist Hospital - Movement Disorders Clinic, Houston, Texas, United States

and more 70 locations

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

First Posted Date
2021-09-16
Last Posted Date
2024-12-16
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
154
Registration Number
NCT05044819
Locations
🇺🇸

Clinical Trial Site, Winchester, Virginia, United States

A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2021-08-30
Last Posted Date
2024-12-13
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
52
Registration Number
NCT05027139
Locations
🇺🇸

Florida Cancer Specialists, Sarasota, Florida, United States

🇺🇸

Astera Cancer Care, East Brunswick, New Jersey, United States

🇺🇸

UC San Diego - Moores Cancer Center, La Jolla, California, United States

and more 8 locations

Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

First Posted Date
2021-07-30
Last Posted Date
2024-12-11
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
56
Registration Number
NCT04984278
Locations
🇨🇿

NeuropsychiatrieHK, Hradec Králové, Czechia

🇪🇸

Hospital Universitario Ramón y Cajal, Madrid, Spain

🇪🇸

Hospital Vithas Nisa Sevilla, Sevilla, Spain

and more 26 locations

Child and Adolescent Registry for Participants With Narcolepsy

Recruiting
Conditions
First Posted Date
2021-05-25
Last Posted Date
2024-08-15
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
500
Registration Number
NCT04899947
Locations
🇺🇸

Children's Hospital of the King's Daughters, Norfolk, Virginia, United States

🇺🇸

Stanford University, Redwood City, California, United States

🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 22 locations

To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

First Posted Date
2021-05-20
Last Posted Date
2024-12-17
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
300
Registration Number
NCT04894591
Locations
🇺🇸

Research Institute & Clinical Alliance, Houston, Texas, United States

🇺🇸

Clearview Cancer Institute, Huntsville, Alabama, United States

🇺🇸

Pacific Cancer Medical Center, Inc, Anaheim, California, United States

and more 47 locations
© Copyright 2024. All Rights Reserved by MedPath